Three Seasons Wealth LLC raised its holdings in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 160.3% during the 1st quarter, Holdings Channel reports. The firm owned 4,466 shares of the company’s stock after buying an additional 2,750 shares during the quarter. Three Seasons Wealth LLC’s holdings in Cardinal Health were worth $944,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also made changes to their positions in the business. Nordea Investment Management AB raised its position in shares of Cardinal Health by 328.3% during the 4th quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock worth $133,741,000 after purchasing an additional 494,731 shares during the last quarter. Procyon Advisors LLC boosted its holdings in Cardinal Health by 78.7% in the 4th quarter. Procyon Advisors LLC now owns 17,025 shares of the company’s stock worth $3,499,000 after buying an additional 7,499 shares during the last quarter. Kornitzer Capital Management Inc. KS boosted its holdings in Cardinal Health by 100.8% in the 4th quarter. Kornitzer Capital Management Inc. KS now owns 18,164 shares of the company’s stock worth $3,733,000 after buying an additional 9,120 shares during the last quarter. Swiss Life Asset Management Ltd increased its stake in Cardinal Health by 73.3% during the 3rd quarter. Swiss Life Asset Management Ltd now owns 76,736 shares of the company’s stock worth $12,044,000 after buying an additional 32,464 shares in the last quarter. Finally, Achmea Investment Management B.V. increased its stake in Cardinal Health by 4.3% during the 3rd quarter. Achmea Investment Management B.V. now owns 203,341 shares of the company’s stock worth $31,917,000 after buying an additional 8,381 shares in the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several research firms have recently weighed in on CAH. William Blair began coverage on Cardinal Health in a research report on Tuesday, April 28th. They issued an “outperform” rating on the stock. Citigroup reiterated a “buy” rating on shares of Cardinal Health in a research report on Thursday, July 2nd. Robert W. Baird set a $248.00 price objective on Cardinal Health in a research note on Friday, May 1st. TD Cowen raised their price objective on Cardinal Health from $255.00 to $275.00 and gave the company a “buy” rating in a report on Thursday, July 9th. Finally, JPMorgan Chase & Co. lowered their target price on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research note on Monday, May 4th. Fifteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $249.13.
Cardinal Health Price Performance
CAH opened at $224.75 on Thursday. The company’s 50 day simple moving average is $214.48 and its two-hundred day simple moving average is $213.51. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $243.21. The firm has a market capitalization of $52.64 billion, a price-to-earnings ratio of 34.37, a price-to-earnings-growth ratio of 1.13 and a beta of 0.49.
Cardinal Health (NYSE:CAH – Get Free Report) last issued its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.38. The business had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities analysts anticipate that Cardinal Health, Inc. will post 10.77 earnings per share for the current fiscal year.
Cardinal Health Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st were paid a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend was Wednesday, July 1st. Cardinal Health’s dividend payout ratio is presently 31.50%.
Cardinal Health Company Profile
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Featured Stories
- Five stocks we like better than Cardinal Health
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
